Nathaniel Calloway
Director/Board Member bij ANEBULO PHARMACEUTICALS, INC.
Vermogen: 149 046 $ op 31-03-2024
Profiel
Nathaniel Calloway is currently the Director at Lifecore Biomedical, Inc., an Independent Director at Anebulo Pharmaceuticals, Inc., and a Healthcare Analyst at 22NW LP.
Previously, he worked as an Analyst at Edison Investment Research, Inc. from 2015 to 2021.
Dr. Calloway holds a graduate degree from The Trustees of Columbia University in The City of New York, a doctorate degree from Cornell University, and an undergraduate degree from The University of North Carolina at Chapel Hill (conferred in 2004).
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-02-2024 | 28 069 ( 0.09% ) | 149 046 $ | 31-03-2024 |
Actieve functies van Nathaniel Calloway
| Bedrijven | Functie | Begin |
|---|---|---|
| ANEBULO PHARMACEUTICALS, INC. | Director/Board Member | 01-11-2022 |
| LIFECORE BIOMEDICAL, INC. | Director/Board Member | 09-01-2023 |
22NW LP
 22NW LP Investment ManagersFinance 22NW LP is an independent registered hedge fund manager headquartered in Seattle, Washington. The firm was founded by Aron English in 2015. It provides investment advice and management to a pooled investment vehicle. | Analyst-Equity | 01-06-2021 |
Eerdere bekende functies van Nathaniel Calloway
| Bedrijven | Functie | Einde |
|---|---|---|
Edison Investment Research, Inc.
 Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Analyst-Equity | 01-06-2021 |
Opleiding van Nathaniel Calloway
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Cornell University | Doctorate Degree |
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| LIFECORE BIOMEDICAL, INC. | Health Technology |
| ANEBULO PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Edison Investment Research, Inc.
Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Finance |
22NW LP
22NW LP Investment ManagersFinance 22NW LP is an independent registered hedge fund manager headquartered in Seattle, Washington. The firm was founded by Aron English in 2015. It provides investment advice and management to a pooled investment vehicle. | Finance |
